Detalles de la búsqueda
1.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587237
2.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587254
3.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
Circulation
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581389
4.
World Stroke Organization Brain & hEart globAl iniTiative Program.
Cerebrovasc Dis
; 53(1): 115-124, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276846
5.
Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial.
Am Heart J
; 265: 132-136, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506747
6.
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Circulation
; 143(12): 1215-1223, 2021 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461308
7.
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med
; 380(16): 1509-1524, 2019 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30883055
8.
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.
Circulation
; 139(20): 2292-2300, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30773022
9.
Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).
J Stroke Cerebrovasc Dis
; 29(9): 104938, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32807412
10.
Sex Disparities in Cardiology: How Are We Doing in Latin America?
Circulation
; 147(7): 521-522, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780382
11.
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
Lancet
; 390(10104): 1737-1746, 2017 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28859942
12.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Lancet
; 389(10081): 1799-1808, 2017 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28325638
13.
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.
Am Heart J
; 197: 133-141, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447773
14.
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Circulation
; 132(8): 624-32, 2015 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26106009
15.
First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina.
Stroke
; 47(6): 1640-2, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27217510
16.
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
Am Heart J
; 175: 175-83, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27179738
17.
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Am Heart J
; 169(1): 25-30, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25497244
18.
Apixaban versus warfarin in patients with atrial fibrillation.
N Engl J Med
; 365(11): 981-92, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21870978
19.
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Am Heart J
; 168(3): 303-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25173541
20.
Thrombin as target for prevention of recurrent events after acute coronary syndromes.
Thromb Res
; 235: 116-121, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38335566